GB Patent

GB0720041D0 — New Compounds

Assigned to Astex Therapeutics Ltd · Expires 2007-11-21 · 18y expired

What this patent protects

Patent listed against Rinvoq.

Drugs covered by this patent

Rinvoq (upadacitinib) · AbbVie Inc.

Patent Metadata

Patent number: GB0720041D0
Jurisdiction: GB
Classification: —
Expires: 2007-11-21
Drug substance claim: No
Drug product claim: No
Assignee: Astex Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.